Oxaliplatin-resistant colorectal cancer cells transport ciRS-122 to oxaliplatin-sensitive cancer cells via exosomes, and ciRS-122 adsorbs miR-122 in drug-sensitive cancer cells, upregulating PKM2, promoting glycolysis of cells and reducing cell susceptibility to drugs [40]. This evidence concerns the gene PKM and colorectal cancer.